Implementierung der S2e-Leitlinie „Ersttrimester Diagnostik und Therapie @ 11-13+6 Schwangerschaftswochen“ – Eine Befragung in ambulanten Praxen
J Schipper(Hannover Re (Germany)), Lars Brodowski(Medizinische Hochschule Hannover), V. Dütemeyer(Medizinische Hochschule Hannover), Andrea Treier(Medizinische Hochschule Hannover), A-L Biermann(Medizinische Hochschule Hannover), Peter Hillemanns(Medizinische Hochschule Hannover), C. v. Kaisenberg(Medizinische Hochschule Hannover), R Menkhaus(Johannes Wesling Klinikum Minden)
Cited by 0
Related Papers
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2
|Nature Genetics|2009|484
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
|JNCI Journal of the National Cancer Institute|2015|441
Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics
|PLoS Genetics|2008|395
Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with <scp>NICE</scp> guidelines and <scp>ACOG</scp> recommendations
|Ultrasound in Obstetrics and Gynecology|2017|363
Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia
|American Journal of Obstetrics and Gynecology|2017|166